FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Gemcitabine Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Mylan Institutional (New 01/25/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Gemcitabine 2g, lyophilized, 1PK (NDC 67457-463-02) 01/25/2018 The discontinuation of this product is a business decision and not related to product quality, safety or efficacy

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English